dacarbazine and Hemorrhagic Disorders

dacarbazine has been researched along with Hemorrhagic Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kopecký, J; Kopecký, O; Macingova, Z; Petera, J; Priester, P; Slovácek, L1

Other Studies

1 other study(ies) available for dacarbazine and Hemorrhagic Disorders

ArticleYear
Aplastic anemia as a cause of death in a patient with glioblastoma multiforme treated with temozolomide.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2010, Volume: 186, Issue:8

    Topics: Anemia, Aplastic; Antineoplastic Agents, Alkylating; Blood Cell Count; Brain Neoplasms; Cause of Death; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Dose Fractionation, Radiation; Female; Frontal Lobe; Glioblastoma; Hemorrhagic Disorders; Humans; Magnetic Resonance Imaging; Middle Aged; Parietal Lobe; Temozolomide

2010